Entrez Id: |
132200 |
Gene Symbol: |
C3orf49 |
C3orf49
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Gene network analysis in a pediatric cohort identifies novel lung function genes.
|
24023788 |
2013 |
Entrez Id: |
54622 |
Gene Symbol: |
ARL15 |
ARL15
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
|
28166213 |
2017 |
Entrez Id: |
284058 |
Gene Symbol: |
KANSL1 |
KANSL1
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
|
28166213 |
2017 |
Entrez Id: |
51319 |
Gene Symbol: |
RSRC1 |
RSRC1
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
|
28166213 |
2017 |
Entrez Id: |
8801 |
Gene Symbol: |
SUCLG2 |
SUCLG2
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
|
28166213 |
2017 |
Entrez Id: |
169714 |
Gene Symbol: |
QSOX2 |
QSOX2
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
|
28166213 |
2017 |
Entrez Id: |
255743 |
Gene Symbol: |
NPNT |
NPNT
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
|
28166213 |
2017 |
Entrez Id: |
64170 |
Gene Symbol: |
CARD9 |
CARD9
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
|
28166213 |
2017 |
Entrez Id: |
55297 |
Gene Symbol: |
CCDC91 |
CCDC91
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
|
28166213 |
2017 |
Entrez Id: |
7145 |
Gene Symbol: |
TNS1 |
TNS1
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
|
28166213 |
2017 |
Entrez Id: |
57178 |
Gene Symbol: |
ZMIZ1 |
ZMIZ1
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
|
28166213 |
2017 |
Entrez Id: |
84665 |
Gene Symbol: |
MYPN |
MYPN
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
|
28166213 |
2017 |
Entrez Id: |
83938 |
Gene Symbol: |
LRMDA |
LRMDA
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
|
28166213 |
2017 |
Entrez Id: |
728489 |
Gene Symbol: |
DNLZ |
DNLZ
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
|
28166213 |
2017 |
Entrez Id: |
56981 |
Gene Symbol: |
PRDM11 |
PRDM11
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analysis identifies six new loci associated with forced vital capacity.
|
24929828 |
2014 |
Entrez Id: |
51741 |
Gene Symbol: |
WWOX |
WWOX
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analysis identifies six new loci associated with forced vital capacity.
|
24929828 |
2014 |
Entrez Id: |
2202 |
Gene Symbol: |
EFEMP1 |
EFEMP1
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analysis identifies six new loci associated with forced vital capacity.
|
24929828 |
2014 |
Entrez Id: |
654 |
Gene Symbol: |
BMP6 |
BMP6
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-wide association analysis identifies six new loci associated with forced vital capacity.
|
24929828 |
2014 |
SLC8A1-AS1
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Entrez Id: |
832 |
Gene Symbol: |
CAPZB |
CAPZB
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Entrez Id: |
100508120 |
Gene Symbol: |
GMDS-DT |
GMDS-DT
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Entrez Id: |
2494 |
Gene Symbol: |
NR5A2 |
NR5A2
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Entrez Id: |
79142 |
Gene Symbol: |
PHF23 |
PHF23
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Entrez Id: |
2869 |
Gene Symbol: |
GRK5 |
GRK5
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Entrez Id: |
387893 |
Gene Symbol: |
KMT5A |
KMT5A
|
Vital capacity
|
0.100 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |